Fusion peptide for inhibiting interaction of neuronal nmda receptor (NMDAR) and NMDAR interacting proteins

Details for Australian Patent Application No. 2007280717 (hide)

Owner Xigen S.A.

Inventors Meyer, Thomas

Agent Cullen & Co

Pub. Number AU-A-2007280717

PCT Pub. Number WO2008/014917

Priority 06015911.8 31.07.06 EP

Filing date 25 July 2007

Wipo publication date 7 February 2008

International Classifications

C07K 14/47 (2006.01) Peptides having more than 20 amino acids

A61K 38/17 (2006.01) Medicinal preparations containing peptides - from animals

Event Publications

8 January 2009 PCT application entered the National Phase

  PCT publication WO2008/014917 Priority application(s): WO2008/014917

4 August 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007280736-Device for capturing the silhouette of an individual

2007280690-Nucleic acid of formula (I): GIXmGn, or (II): CIXmCn, in particular as an immune-stimulating agent/adjuvant